|Day Low/High||16.96 / 17.30|
|52 Wk Low/High||15.22 / 51.51|
Law Offices of Howard G. Smith continues its investigation on behalf of Teva Pharmaceutical Industries Ltd.
Teva Pharmaceutical Industries Ltd. (NYSE and TASE:TEVA) and Nuvelution Pharma, Inc.
Teva Pharmaceutical Industries Ltd., (NYSE and TASE: TEVA) today announced amendments to its USD and JPY term loan and revolving credit facilities, providing Teva greater flexibility in its financial leverage ratio...
The S&P 500 and Dow score new records. Here's where stocks settled on Monday.
Stocks aim for new records. Here's where stocks are trading at the session midway mark on Monday.
Stocks aim for new records with markets in a generally upbeat mood ahead of a decision on interest rates from the Federal Reserve this week.
Today, two leading private sector groups announced a partnership to create scalable solutions to improve patient and health system care for Multiple Chronic Conditions.
Stocks aim for new records. Here's where stocks are trading at the market open on Monday.
Teva Pharmaceutical Industries Ltd., (NYSE and TASE: TEVA) today announced it has entered into two agreements to sell the remaining assets of its specialty global women's health business for $1.
The Israel-based drugmaker on Monday tapped Kare Schultz as its new CEO. Schultz, who hails from Denmark-based Lundbeck, succeeds Dr. Yitzhak Peterburg, who has served as interim CEO since February.
The Klein Law Firm announces that a class action complaint has been filed on behalf of shareholders of Teva Pharmaceutical Industries Ltd.
Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA) today announced the presentation of 12 posters at the upcoming 2017 Psych Congress, September 16-19 in New Orleans, Louisiana.
The Law Offices of Vincent Wong announce that a class action lawsuit has been commenced in the United States District Court for the Eastern District of Pennsylvania on behalf of investors who purchased Teva Pharmaceutical...
The following statement is being issued by Levi & Korsinsky, LLP: To: All persons or entities who purchased or otherwise acquired American Depositary Shares of Teva Pharmaceutical Industries Ltd.
Teva Pharmaceutical Industries Ltd. (NYSE: TEVA) announced today the U.
In August 2016, Teva completed its purchase of Allergan's generic drug business for $33.4 billion in cash and $5.4 billion in stock
Teva's New York-listed shares were up 7.63% in premarket trading, indicated to open at $19.90
Here's what you need to know now for Monday, September 11.
Teva Pharmaceutical Industries Ltd., (NYSE and TASE: TEVA) today announced it has entered into a definitive agreement under which CooperSurgical will acquire PARAGARD ® (intrauterine copper contraceptive), a product...
Wall Street starts the week with a rally.
The Dow is up more than 250 points.
The world's biggest generic drug maker Monday named Kare Schultz as president and CEO, ending months of speculation about who would replace former head Erez Vigodman, who left the company in February for undisclosed reasons.
Sign up to get started or log in to see your watchlist.
Enter a symbol above to add it to your watchlist.